Zimbabwe has turned down a significant American healthcare agreement valued at $367m (272 million pounds) over five years over the United States' request for confidential biological samples.
The decision came to light after a internal memorandum dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the agreement was "skewed".
An official spokesperson has since explained that the United States was requesting genetic material for scientific study and commercial gain while was not willing to guarantee the benefits from future treatments.
"We are forced to start the challenging and unfortunate process of ending our support in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.
The US Embassy noted the US had furnished more than $1.9bn for health programmes to Zimbabwe over the last twenty years.
A doctors' association in Zimbabwe has appealed for more talks to secure a agreement agreeable to both sides so the nation's critical HIV treatment initiative can proceed.
Broader Background
This development follows a comparable situation in neighbouring Kenya, where a court blocked a related deal with the US after concerns were filed about the security of citizens' health data.
Since resuming the presidency recently, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.
USAID had managed aid for the US government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government deals to boost openness and accountability.
According to reports, Sixteen African countries have to date signed similar health pacts, constituting more than $18.3bn of fresh investment.
Details of the Rejected Agreement
The funds for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.
"It is our view this collaboration could have provided immense advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently receiving antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the proposed deal was "unequal".
"Our nation was requested to surrender its genetic material and health information indefinitely, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that provided information," he stated.
"In essence, our country would supply the raw materials for medical research with no assurance that the end products would be available to our people if a new health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one deals were upending structures previously set up through the global organization.
The spokesperson gave as an example its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.
"This system is designed to ensure that when a country provides its samples, the resulting advantages – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to create them."
These objections regarding the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how future collaboration could be structured in a manner that respects the sovereignty and dignity of both nations."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the official position, but recommended that negotiations need to persist given that a large portion of the nation's Aids initiatives depended on foreign aid.
"In cases where specific concerns exist, such as those relating to information security or agreement terms, these can often be addressed via technical clarification and mutually agreed protections," the group added.
The halted deal highlights the ongoing tensions between receiving vital international aid and protecting national sovereignty in an increasingly data-driven world.